Category Archives: Public Policy

Latest From Public Policy

PA Bio Names State Official of the Year

admin-ajax (1)

Pennsylvania State Representative Warren Kampf was selected as the recipient Pennsylvania Bio’s 2013 State Official of the Year Award. Representative Kampf will be honored at Pennsylvania Bio’s Annual Dinner and Awards Celebration on March 12th at the Pennsylvania Convention Center in Philadelphia.  The State Official of the Year recognizes a public official from the Commonwealth of Pennsylvania who has distinguished him/herself as a leader in the bioscience industry. The honoree is selected by the Pennsylvania Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Special 301: BIO Highlights Challenges in India

cells115x76

BIO recently testified before the U.S. government on the intellectual property challenges our members face in various markets around the world. Among other matters, BIO recommended that the U.S. government designate India as a Priority Foreign Country, a designation that would lead to the consideration of trade sanctions for treaty violations. Specifically, BIO testified: “In the healthcare space, only a few dozen innovative and patent protected medicines are on the market in India. Yet, in Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Bioterrorism: Assessing the Threat

AB23475

Recently, the House of Representatives Homeland Security Committee Subcommittee on Emergency Preparedness, Response, and Communications held a hearing on bioterrorism and biological warfare.Tom Inglesby, MD, University of Pittsburgh Medical Center, Center for Health Security and Robert P. Kadlec, MD, Center for a New American Security, presented testimony outlining their concerns on current threats to public safety and recommendations for emergency preparedness. Drs. Inglesby and Kadlec asserted that the risk of biological attacks on the U.S. Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

A New Addition to Pennsylvania Bio’s Leadership Team

ct-115x76

To effectively achieve our mission as the champion and advocate of biotechnology, BIO works with a broad network of organizations. Foremost among these relationships are the ones we possess with a broad network of state-based organizations known as the Council of State Bioscience Associations (CSBA). Pennsylvania Bio (PA Bio) has been a key ally to BIO and vocal advocate for state and federal public policy in support of the biotechnology industry since our inception. Just Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Report Shows World’s Weakest IP Environments

admin-ajax

There is clear link between a country’s rate of economic development and the strength of its intellectual property laws. This is particularly true in knowledge-intensive sectors such as biopharmaceuticals. The good news is that some mature and emerging economies are making growing use of patent systems to facilitate biotechnology research and commercialization. The bad news is that a number of countries, including India, China, Brazil and Canada, have established bureaucratic and burdensome hurdles to patentability. Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,